With disparate findings on the association of p16 and NPC in published literature, our results are hypothesis-generating and need larger prospective studies to better illustrate the impact of p16 status on clinical outcomes in patients with NPC. This evidence concerns the gene CDKN2A and nasopharyngeal carcinoma.